Skip to content
Longterm Wiki
grant

Kainomyx — Antimalarial Drug (2021)

Child of Coefficient Giving

Metadata

Source Tablegrants
Source ID9DPzJrUZkm
Descriptionto Kainomyx, USD 4000000, 2021-09
Source URLcoefficientgiving.org/funds/
ParentCoefficient Giving
Children
CreatedMar 12, 2026, 5:54 AM
UpdatedMar 22, 2026, 2:59 AM
SyncedMar 19, 2026, 8:57 PM

Record Data

id9DPzJrUZkm
organizationIdCoefficient Giving(organization)
granteeIdKainomyx
orgEntityIdCoefficient Giving(organization)
orgDisplayName
granteeEntityId
granteeDisplayNameKainomyx
nameKainomyx — Antimalarial Drug (2021)
amount4000000
currencyUSD
period
date2021-09
status
sourcecoefficientgiving.org/funds/
notes[Other Scientific Research Areas] Open Philanthropy recommended an investment of $4,000,000 in Kainomyx to develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis. If effective, the new drugs would act by inhibiting cytoskeletal protei
programIdB4pZkOtjSk
dataSourceId

Source Check Verdicts

confirmed95% confidence

Last checked: 4/9/2026

[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Debug info

Thing ID: 9DPzJrUZkm

Source Table: grants

Source ID: 9DPzJrUZkm

Parent Thing ID: sid_ULjDXpSLCI